BDBM651000 2'-[(2S,5R)-2,5-dimethyl-4-(prop- 2-enoyl)piperazin-1-yl]-15',18',21'- trifluoro-6'-(propan-2-yl)-10',11'- dihydro-4'H,13'H- spiro[cyclopropane-1,12'-[14]oxa [3,5,7,20]tetraaza[1,19] (ethanediylidene)pyrido[4,3- f]pyrimido[1,6-h][1,8,10] benzoxadiazacyclotri- decin]-4'-one::US20240043448, Example 61

SMILES CC(C)c1nccc2CCC3(CC3)COc3c(F)ccc(F)c3-c3nc4n(-c12)c(=O)nc(N1C[C@@H](C)N(C[C@@H]1C)C(=O)C=C)c4cc3F

InChI Key InChIKey=VDWOYYOINQZRMD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 651000   

TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM651000(2'-[(2S,5R)-2,5-dimethyl-4-(prop- 2-enoyl)piperazi...)
Affinity DataIC50: 2.30nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent